New design produces true lithium-air battery
Researchers at the University of Illinois at Chicago and at Argonne National Laboratory have designed a new lithium-air battery that works in a natural air environment and still functioned after a record-breaking 750 charge/discharge cycles. Their findings are reported in the journal Nature.
DOD grant to test promising treatment for triple-negative breast cancer
A unique cell surface protein found on triple-negative type breast cancer cells called JAG1 is a promising new therapeutic target for this hard-to-treat and highly metastatic type of breast cancer, according to researchers at the University of Illinois at Chicago. Jan Kitajewski, professor and head of physiology and biophysics at UIC, and his colleagues are working on developing a small drug molecule that can block JAG1.
How does the lung microbiome influence sarcoidosis?
Researchers from the University of Illinois at Chicago have received a $2.7 million, 4-year grant from the National Institutes of Health to investigate possible links between the lung microbiome and sarcoidosis. Sarcoidosis is an inflammatory disease that attacks multiple organs, particularly the lungs and lymph nodes, and disproportionately affects African Americans. Pulmonary fibrosis is the number-one cause of death among sarcoidosis patients. Approximately 30 percent of patients develop a progressive, debilitating form of sarcoidosis, but the mechanisms responsible for driving worsening or resilience to the disease remain poorly understood.
Graphene oxide nanosheets could help bring lithium-metal batteries to market
Lithium-metal batteries — which can hold up to 10 times more charge than the lithium-ion batteries that currently power our phones, laptops and cars — haven’t been commercialized because of a fatal flaw: as these batteries charge and discharge, lithium is deposited unevenly on the electrodes. This buildup cuts the lives of these batteries too short to make them viable, and more importantly, can cause the batteries to short-circuit and catch fire.
Researchers investigate the role of arsenic in the development of diabetes
A five-year, $2.7 million grant from the National Institute of Environmental Health Sciences will help researchers at the University of Illinois at Chicago answer basic questions about the role of arsenic in the development of diabetes and examine the mechanisms by which selenoproteins – found in the human body in 25 different forms – counter the effects of arsenic.